alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# Official Journal L 238/2020

| | ISSN 1977-0677 |
| --- | --- |
| Official Journal
  of the European Union | L 238 |
| | |
| English edition | Legislation | Volume 6323 July 2020 |

ISSN 1977-0677

Official Journal

of the European Union

L 238

English edition

Legislation

Volume 6323 July 2020

---

| Contents | | II   Non-legislative acts | page |
| --- | --- | --- | --- |
| | | REGULATIONS |
| | * | Commission Implementing Regulation (EU) 2020/1080 of 22 July 2020 imposing a definitive anti-dumping duty on imports of solar glass originating in the People’s Republic of China following an expiry review pursuant to Article 11(2) of Regulation (EU) 2016/1036 of the European Parliament and of the Council | 1 |
| | * | Commission Implementing Regulation (EU) 2020/1081 of 22 July 2020 imposing definitive countervailing duties on imports of solar glass originating in the People’s Republic of China following an expiry review pursuant to Article 18 of the Regulation (EU) 2016/1037 of the European Parliament and of the Council | 43 |
| | * | Commission Implementing Regulation (EU) 2020/1082 of 22 July 2020 amending for the 315th time Council Regulation (EC) No 881/2002 imposing certain specific restrictive measures directed against certain persons and entities associated with the ISIL (Da'esh) and Al-Qaida organisations | 82 |

Contents

II   Non-legislative acts

page

REGULATIONS

*

Commission Implementing Regulation (EU) 2020/1080 of 22 July 2020 imposing a definitive anti-dumping duty on imports of solar glass originating in the People’s Republic of China following an expiry review pursuant to Article 11(2) of Regulation (EU) 2016/1036 of the European Parliament and of the Council

1

*

Commission Implementing Regulation (EU) 2020/1081 of 22 July 2020 imposing definitive countervailing duties on imports of solar glass originating in the People’s Republic of China following an expiry review pursuant to Article 18 of the Regulation (EU) 2016/1037 of the European Parliament and of the Council

43

*

Commission Implementing Regulation (EU) 2020/1082 of 22 July 2020 amending for the 315th time Council Regulation (EC) No 881/2002 imposing certain specific restrictive measures directed against certain persons and entities associated with the ISIL (Da'esh) and Al-Qaida organisations

82

| EN | Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.
  The titles of all other Acts are printed in bold type and preceded by an asterisk. |
| --- | --- |

EN

Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.

The titles of all other Acts are printed in bold type and preceded by an asterisk.
Exhibit 31.1  EXHIBIT 31.1 CERTIFICATION PURSUANT TO 18 U.S.C. ss. 1350, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002  I, Conrad R Huss, certify that:  1. I have reviewed this annual report on Form 10-K of Brazil Gold Corp.  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;  3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;  4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and I have:  a) designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;  b) evaluated the effectiveness of the registrant's disclosure controls and procedures as of a date within ninety (90) days prior to the filing date of this quarterly report (the "Evaluation Date"); and  c) presented in this report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;  5. The registrants other certifying officer and I have disclosed, based on our most recent evaluation, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent function):  a) all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant's ability to record, process, summarize and report financial data and have identified for the registrant's auditors any material weaknesses in internal controls; and  b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls; and  6. The registrants other certifying officer and I have indicated in this report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.   Date:  September 30, 2013  By: /s/Conrad R. Huss Name: Conrad R. Huss Title: Director, Chief Executive Officer, Secretary, Chief Financial Officer
CERTIFICATION PURSUANT TO
                                              18 U.S.C. SECTION 1350
                                              AS ADOPTED PURSUANT TO
                                   SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 In connection with the Annual Report of Trust Licensing, Inc. (the "Company")
on Form 10- KSB for the period ending December 31, 2003 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I Jeffrey
Sass, Chief Executive Officer and Jay Howard Linn, Chief Financial Officer
of the Company, certify, pursuant to 18 U.S.C. ss.1350, as adopted pursuant to
ss.906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 1. The Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934, and

2. The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.

                            By: /s/  Jeffrey Sass, Chief Executive Officer


                            By: /s/ Jay Howard Linn, Chief Financial Officer

 Date: November 11, 2004

A signed original of this written statement required by Section 906 has been
provided to the Company and will be retained by the Company and furnished to the
Securities and Exchange Commission or its staff upon request.
EXHIBIT 32.1

CERTIFICATION OF PERIODIC REPORT

The undersigned Chairman of the Board, Chief Executive Officer and President and Executive Vice President and Chief Financial Officer of Marquee
Holdings Inc. (the "Company"), each hereby certifies, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:



|Dated: June 18, 2008                                                                                   |  |  | 
|------------------------------------------------------------------------------------------------------ |  |  | 
|/s/PETER C. BROWNPeter C. Brown Chairman of the Board, Chief Executive Officer, Director and
President |  |  | 
|/s/CRAIG R. RAMSEYCraig R. Ramsey Executive Vice President and Chief Financial Officer                 |  |  | 

[A
signed original of this written statement required by Section 906 has been provided to Marquee Holdings Inc. and will be retained by Marquee Holdings Inc. and
furnished to the Securities and Exchange Commission or its staff upon request.]

---



QuickLinks
Michigan Supreme Court

Lansing, Michigan

Stephen J. Markman, Chief Justice

Brian K. Zahra

Bridget M. McCormack

David F. Viviano 

Richard H. Bernstein

Joan L. Larsen

Kurtis T. Wilder,

Justices

I, Larry S. Royster, Clerk of the Michigan Supreme Court, certify that the

foregoing is a true and complete copy of the order entered at the direction of the Court.

 September 1, 2017

Order 

Clerk

September 1, 2017

154442(145)

ALI BAZZI,

Plaintiff-Appellant,

and

GENEX PHYSICAL THERAPY, INC. and 

ELITE CHIROPRACTIC CENTER, PC,

Intervening Plaintiffs-Appellants,

and

TRANSMEDIC, LLC,

Intervening Plaintiff-Appellee,

SC: 154442

v COA: 320518

Wayne CC: 13-000659-NF

SENTINEL INSURANCE COMPANY,

Defendant/Third-Party

Plaintiff-Appellee,

and

CITIZENS INSURANCE COMPANY,

Defendant-Appellee,

and

HALA BAYDOUN BAZZI and

MARIAM BAZZI, Third-Party Defendants-Appellees.

________________________________________/

On order of the Chief Justice, the motion of defendant/third-party plaintiffappellee to extend the time for filing its brief on appeal is GRANTED. The brief will be 

accepted as timely filed if submitted on or before October 11, 2017.
<PAGE>   1
                                                                EXHIBIT 11


                    VIRCO MFG. CORPORATION AND SUBSIDIARIES

                Statement Re: Computation of Earnings Per Share


<TABLE>
<CAPTION>

                                                                                        1997            1996
                                                                                     ----------      ----------
                                                                                        Three Months Ended
                                                                                     --------------------------
                                                                                             April 30
                                                                                             --------
<S>                                                                                   <C>             <C>      
Primary:
Average Shares Outstanding                                                            5,906,296       5,906,296

Net effect of dilutive stock options - based on the treasury stock method using
average market price 
                                                                                        124,528               -
                                                                                     ----------      ----------

Totals                                                                                6,030,824       5,906,296
                                                                                     ==========      ==========

Net Income/(Loss)                                                                       499,000      (1,439,000)
                                                                                     ==========      ==========

Per Share Amount                                                                            .08            (.24)
                                                                                     ==========      ==========
</TABLE>




Weighted average shares outstanding are adjusted for 10% stock dividend declared
August 20, 1996.
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2636 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2636

    To extend the temporary suspension of duty on mixtures of C5-18 
perfluorocarbon alkanes, perfluorocarbon amines, and/or perfluorocarbon 
                                ethers.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 7, 2012

 Ms. Klobuchar introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
    To extend the temporary suspension of duty on mixtures of C5-18 
perfluorocarbon alkanes, perfluorocarbon amines, and/or perfluorocarbon 
                                ethers.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. MIXTURES OF C5-18 PERFLUOROCARBON ALKANES, PERFLUOROCARBON 
              AMINES, AND/OR PERFLUOROCARBON ETHERS.

    (a) In General.--Heading 9902.40.88 of the Harmonized Tariff 
Schedule of the United States (relating to mixtures of C5-18 
perfluorocarbon alkanes, perfluorocarbon amines, and/or perfluorocarbon 
ethers) is amended by striking the date in the effective period column 
and inserting ``12/31/2015''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
M A N D A T E

TO THE 343RD DISTRICT COURT of SAN PATRICIO COUNTY, GREETINGS:

Before our Court of Appeals for the Thirteenth District of Texas, on the 17th day of July,

2014, the cause upon appeal to revise or reverse your judgment between

MARK BERNHARD, Appellant,

v.

CITY OF ARANSAS PASS, TEXAS Appellee.

CAUSE NO. 13-13-00354-CV (Tr.Ct.No. S-12-5831-CV-C)

was determined; and therein our said Court made its order in these words:

JUDGMENT

THE THIRTEENTH COURT OF APPEALS, having considered the parties’ joint motion

to vacate, vacates and withdraws the judgment that this Court issued on July 17, 2014;

however, the opinion previously issued in this cause will not be withdrawn. The Court

reinstates the trial court’s order of January 24, 2013 granting the plea to the jurisdiction

filed by the City of Aransas Pass, Texas, and we dismiss the appeal. Costs of the

appeal are adjudged against appellant.

We further order this decision certified below for observance.

September 24, 2014

      

WHEREFORE, WE COMMAND YOU to observe the order of our said Court of Appeals

for the Thirteenth District of Texas, in this behalf, and in all things have it duly

recognized, obeyed and executed.

WITNESS, the Hon. Rogelio Valdez, Chief Justice of our Court of Appeals, with the seal

thereof affixed, at the City of Edinburg, Texas this 30th day of January, 2015.

Dorian E. Ramirez, CLERK

FILE COPY
# Official Journal C 10/10 J

| | ISSN 1977-091X |
| --- | --- |
| Official Journal
  of the European Union | C 10 |
| | |
| English edition | Information and Notices | Volume 6210 January 2019 |

ISSN 1977-091X

Official Journal

of the European Union

C 10

English edition

Information and Notices

Volume 6210 January 2019

---

| Contents | page |
| --- | --- |
| | III   Preparatory acts |
| | COURT OF AUDITORS |
| 2019/C 10/01 | Opinion No 9/2018 (pursuant to Article 287(4) TFEU) concerning the proposal for a Regulation of the European Parliament and of the Council establishing the EU Anti-Fraud Programme | 1 |

Contents

page

III   Preparatory acts

COURT OF AUDITORS

2019/C 10/01

Opinion No 9/2018 (pursuant to Article 287(4) TFEU) concerning the proposal for a Regulation of the European Parliament and of the Council establishing the EU Anti-Fraud Programme

(pursuant to Article 287(4) TFEU)

1

---

| EN | |
| --- | --- |

EN
CONSOLIDATED HEALTH CARE ASSOCIATES, INC.
                           38 Pond Street, Suite 305
                         Franklin, massachusetts 02038

FOR IMMEDIATE RELEASE

September 30, 1997

Contact: Robert M. Whitty, President & CEO
         (508)-520-2422

            CONSOLIDATED HEALTH CARE ANNOUNCES REVISED PROPOSED SALE

FRANKLIN, MA - Consolidated Health Care Associates, Inc. (NASDAQ:CHCA) announces
the signing of a revised non-binding letter of intent with Olympus Healthcare
Group, Inc. whereby Olympus will acquire all of the operating assets and assume
certain liabilityes of PTS Rehab, Inc. and Consolidated Rehabilitation Services,
Inc., wholly owned subsidiaries of Consolidated Health Care Associates, Inc. in
exchange for 42,553 shares of common stock of Olympus and $1,400,000 cash,
subject to completion of due diligence, signing of a definitive agreement and
approval of Consolidated shareholders and certain other customary conditions. It
is anticipated that the transaction will close after a shareholders meeting in
October.

Robert M. Whitty, President of Consolidated, stated "This revised transaction
with Olympus which constitutes the sale of the Company's Massachusetts
outpatient clinics and the Company's Contract Service business in Massachusetts
and New York, is anticipated to be beneficial for all of the clients and
employees of the respective Consolidated subsidiaries."

The Company also announced that Consolidated will pursue the sale of the
remaining Company's outpatient clinics in Delaware and Pennsylvania. Proceeds
from the transactions, along with the collections of the Company's receivables,
will be used to satisfy the Company's outstanding liabilities. There are no
assurances that such transactions will enable the Company to completely pay all
liabilities.

Olympus Healthcare Group, Inc. is a privately owned, integrated post acute
healthcare services company, located in Westborough, Massachusetts. Olympus
provides a variety of post acute health care services in a number of sites
ranging from inpatient (hospitals, skilled nursing facilities) to ambulatory
(outpatient, day treatment center, home) throughout the New England region.
EXHIBIT 32.1


CERTIFICATION PURSUANT TO 18 U. S. C. § 1350,


AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the Annual Report of Education Realty Trust, Inc. (the “Trust”) on Form 10-K for the period ended December 31 2010, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Randy Churchey, Chief Executive Officer of the Trust, certify, in my capacity as an officer of the Trust, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:





(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Trust.





Date: March 7, 2011





/s/ Randy ChurcheyRandy ChurcheyChief Executive Officer





In accordance with SEC Release No. 34-47986, this Exhibit is furnished to the SEC as an accompanying document and is not deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933.
II 

112TH CONGRESS 

2D SESSION S. 2431 

To extend the temporary suspension of duty on cis-3-hexen-1-ol. 

IN THE SENATE OF THE UNITED STATES 

APRIL 26, 2012 

Mr. SCHUMER introduced the following bill; which was read twice and referred 

to the Committee on Finance 

A BILL 

To extend the temporary suspension of duty on cis-3-hexen1-ol. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. CIS-3-HEXEN-1-OL. 

4 (a) IN GENERAL.—Heading 9902.02.99 of the Har5 monized Tariff Schedule of the United States (relating to 

6 cis-3-hexen-1-ol) is amended by striking the date in the 

7 effective period column and inserting ‘‘12/31/2015’’. 

8 (b) EFFECTIVE DATE.—The amendment made by 

9 subsection (a) applies to goods entered, or withdrawn from 

mstockstill on DSK4VPTVN1PROD with BILLS

2 

•S 2431 IS

1 warehouse for consumption, on or after the 15th day after 

2 the date of the enactment of this Act. 

Æ 

mstockstill on DSK4VPTVN1PROD with BILLS
EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 

In connection with the Quarterly Report of Sierra Health Services, Inc. (the Company) on Form 10-Q for the period ending June 30, 2004 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Anthony M. Marlon, M.D., Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that: 

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and 

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
EXHIBIT 99.2

                                  CERTIFICATION

This certification is provided pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002 and accompanies the quarterly  report on Form 10-Q (the "Form 10-Q") for
the quarter ended March 31, 2003 of American Insured Mortgage Investors - Series
85, L.P. (the "Issuer").

I,  Cynthia O.  Azzara,  Senior  Vice  President,  Chief  Financial  Officer and
Treasurer, certify that to the best of my knowledge:

     (i)  the Form 10-Q fully complies with the requirements of section 13(a) or
          section 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a)
          or 78o(d)); and

     (ii) the information  contained in the Form 10-Q fairly represents,  in all
          material respects,  the financial  condition and results of operations
          of the Issuer.


                                  AMERICAN INSURED MORTGAGE
                                  INVESTORS - SERIES 85, L.P.
                                  (Registrant)

                                  By:  CRIIMI, Inc.
                                       General Partner



May 13, 2003                      /s/ Cynthia O. Azzara
------------                      ----------------------------------------------
Date                              Cynthia O. Azzara
                                  Senior Vice President, Chief Financial Officer
                                  and Treasurer
EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 

In connection with the Quarterly Report of Sierra Health Services, Inc. (the Company) on Form 10-Q for the period ending September 30, 2004 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Paul H. Palmer, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that: 

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and 

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.